Hyung Sik Kim

Professor

Sungkyunkwan University - Natural Sciences Campus

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hyung Sik Kim is a Professor at Sungkyunkwan University - Natural Sciences Campus in South Korea (+82). His research focuses on various aspects of pharmacology and biotechnology, including the therapeutic effects of natural remedies, the role of cell-penetrating peptides in bone formation, and cancer treatment strategies involving new drug combinations. Recent publications highlight his work on drug resistance in cancer populations, metabolic disorders, and the protective effects of specific compounds against toxicity.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Yoo-Kyung Song

Korea Research Institute of Bioscience and Biotechnology

SOUTH KOREA

View details

Yoonjee Chae

Woosuk University

SOUTH KOREA

View details

In Su Kim

SOUTH KOREA

View details

SungHo Lee

Research Professor

Chonnam National University

SOUTH KOREA

View details

Sungpil Yoon

Sungkyunkwan University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hyung Sik Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The Cell-Penetrating Peptide GV1001 Enhances Bone Formation via Pin1-Mediated Augmentation of Runx2 and Osterix Stability

Exploring the Metabolic Effects of a Herbal Remedy of Asarum sieboldii, Platycodon grandiflorum, and Cinnamomum cassia Extracts: Unraveling Its Therapeutic Potential as a Topical Application for Atopic Dermatitis Treatment

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans

Metallothionein 3 Inhibits 3T3-L1 Adipocyte Differentiation via Reduction of Reactive Oxygen Species

First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations

Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy

Protective effect of dendropanoxide against cadmium-induced hepatotoxicity via anti-inflammatory activities in Sprague-Dawley rats

Risk Assessment and Risk Reduction of Ptaquiloside in Bracken Fern

Novel Specific Pyruvate Kinase M2 Inhibitor, Compound 3h, Induces Apoptosis and Autophagy through Suppressing Akt/mTOR Signaling Pathway in LNCaP Cells

Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity

Tenovin-1 Ameliorates Renal Fibrosis in High-Fat-Diet-Induced Diabetic Nephropathy via Antioxidant and Anti-Inflammatory Pathways

<i>Molineria recurvata</i> Ameliorates Streptozotocin-Induced Diabetic Nephropathy through Antioxidant and Anti-Inflammatory Pathways

Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity

Collaborators (5)

Yoo-Kyung Song

Yoonjee Chae

In Su Kim

SungHo Lee

Sungpil Yoon

Make your next move.